Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation

Share Article

The Firm is representing a number of plaintiffs who have testosterone treatment lawsuits pending in federal court, all of whom allegedly suffered serious cardiovascular problems due to their use of the medications.

Free Case Review
We are pleased to see the federal testosterone lawsuits moving ahead, and look forward to more progress in this litigation in the coming months.

Testosterone lawsuits (http://www.testosteronelawsuithub.com/) filed on behalf of men who allegedly suffered heart attacks, strokes and other serious cardiovascular events due to their use of prescription low testosterone therapies continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois. According to a Case Management Order issued on March 3rd, the Court has set forth procedures for the use of master pleadings in the proceeding. Among other things, the Order directs plaintiffs to file a Master Complaint and Short Form Complaint with the Court by March 17th. The Defense is to file a Master Answer within 45 days of the filing of the Master Complaint. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“The use of master pleadings such as those outlined by this Order simplify the procedures for filing a lawsuit. We are pleased to see the federal testosterone lawsuits moving ahead, and look forward to more progress in this litigation in the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing a number of clients who have testosterone lawsuits pending in the federal proceeding, and continues to offer free case reviews to men who may have been harmed by low testosterone treatments.

Testosterone Allegations

Court documents indicate that more than 1,000 testosterone lawsuits are currently pending in the Northern District of Illinois, where all federally-filed claims involving this class of prescription medications have been consolidated for the purposes of coordinated pretrial proceedings. All of the claims similarly allege that the manufacturers of testosterone replacement therapies concealed the cardiovascular risks allegedly associated with the drugs, including an increased risk of heart attacks, strokes, deep vein thrombosis and pulmonary embolism. Plaintiffs further claim that sales of the drugs were driven by aggressive direct-to-consumer advertising that touted low-T therapy as a remedy for symptoms associated with age related drops in testosterone, an indication for which they have not been approved.

According to court records, the federal testosterone litigation was established in June 2014, roughly six months after the U.S. Food & Drug Administration (FDA) disclosed that it was investigating the cardiovascular side effects potentially associated with testosterone replacement therapy.* On March 3, 2015, the FDA announced that it was mandating that new information be added to the drug’s labels in order to warn patients that testosterone treatment may increase their risk for heart attacks and strokes. In addition, the agency is also requiring testosterone manufacturers to update their product labels to clarify their approved uses, as the drugs are only indicated to treat men who suffer from hypogonadism (low testosterone levels) due to disorders of the testicles, pituitary gland, or brain.

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website